Survival benefit from first docetaxel treatment for cabazitaxel plus prednisone compared with mitoxantrone plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in the TROPIC trial.
JOURNAL OF CLINICAL ONCOLOGY, vol.29, no.15, 2011 (SCI-Expanded, Scopus)
- Publication Type: Article / Abstract
- Volume: 29 Issue: 15
- Publication Date: 2011
- Doi Number: 10.1200/jco.2011.29.15_suppl.4525
- Journal Name: JOURNAL OF CLINICAL ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Istanbul University-Cerrahpasa Affiliated: No